Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13

The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%);...

Full description

Saved in:
Bibliographic Details
Published inEuro surveillance : bulletin européen sur les maladies transmissibles Vol. 18; no. 5; p. 1
Main Authors McMenamin, J, Andrews, N, Robertson, C, Fleming, Dm, Durnall, H, von Wissmann, B, Ellis, J, Lackenby, A, Cottrell, S, Smyth, B, Zambon, M, Moore, C, Watson, Jm, Pebody, Rg
Format Journal Article
LanguageEnglish
Published Sweden Centre Europeen pour la Surveillance Epidemiologique du SIDA (European Centre for the Epidemiological Monitoring of AIDS) 31.01.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The early experience of the United Kingdom (UK) is that influenza B has dominated the influenza 2012/13 season. Overall trivalent influenza vaccine (TIV) adjusted vaccine effectiveness (VE) against all laboratory-confirmed influenza in primary care was 51% (95% confidence interval (CI): 27% to 68%); TIV adjusted VE against influenza A alone or influenza B alone was 49% (95% CI: -2% to 75%) and 52% (95% CI: 23% to 70%) respectively. Vaccination remains the best protection against influenza.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1560-7917
1025-496X
1560-7917
DOI:10.2807/ese.18.05.20393-en